Skip to main content

Joan Joseph Munné

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Joan Joseph Munné

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Projects

NANOVAC: Una nueva plataforma vacunal de inducción-refuerzo como vacuna bivalente frente al VIH/TB. Evaluación in vivo de BCG :VIH y nanopartículas de oro como candidatos de vacuna en ratones BALB/c

IP: Joan Joseph Munné
Collaborators: Joana Ramis Garcia, Claudia Broto Cortes
Funding agency: Instituto de Salud Carlos III
Funding: 102500
Reference: PI24/00576
Duration: 01/01/2025 - 31/12/2027

Grup de Recerca en Microbiologia de Hospital Universitari Vall d'Hebron

IP: Juan Jose Gonzalez Lopez
Collaborators: María Nieves Larrosa Escartin, Maria Belén Viñado Perez, Gema Codina Grau, Virginia Rodríguez Garrido, Andres Antón Pagarolas, Juliana Esperalba Esquerra, Ariadna Rando Segura, Alba Mir Cros, Yannick Hoyos Mallecot, Joan Joseph Munné, Tomàs Pumarola Suñé, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Albert Moreno Mingorance, Maria Piñana Moro, Grup de Recerca en Microbiologia de Hospital Universitari Vall d'Hebron, Elena Sulleiro Igual, Grup de Recerca en Microbiologia de Hospital Universitari Vall d'Hebron, Josep Roca Grande, Alejandra Gonzalez Sánchez, Narcís Saubí Roca, Jesus Trejo Zahinos
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01129
Duration: 01/01/2022 - 30/06/2025

Pre-clinical evaluation of safety and immunogenicity of recombinant BCG expressing SIV:consv in Cynomolgus macaques. A new platform for a bivalent HIV/TB vaccine development

IP: Joan Joseph Munné
Collaborators: Vicente Descalzo Jorro
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI20/00217
Duration: 01/01/2021 - 30/06/2025

European AIDS Vaccine Initiative 2020 (EAVI2020)

IP: Joan Joseph Munné
Collaborators: Narcís Saubí Roca
Funding agency: EUROPEAN COMMISSION
Funding: 195142.58
Reference: EAVI_H2020
Duration: 01/06/2019 - 31/12/2022

Related news

All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

The project has developed a low-cost system to diagnose malaria and schistosomiasis using artificial intelligence and a robotic microscope.

Related professionals

Andrea Freixa Benavente

Andrea Freixa Benavente

Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Maria Baladas Orti

Maria Baladas Orti

Research technician
Stroke research
Read more
Laura Rubio Guerrero

Laura Rubio Guerrero

Gestió i Administració
Purchase and Biddings Unit
Finance Directorate
Read more
Javier Francisco Ramon Pasías

Javier Francisco Ramon Pasías

Postdoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.